ADVANCED EPITHELIAL OVARIAN CANCER: THE PROGNOSTIC SIGNIFICANCE OF RESIDUAL DISEASE AFTER CYTOREDUCTIVE SURGERY

Clinical and pathological predictors of the response to neoadjuvant anthracycline chemotherapy in locally advanced breast cancer

The Prognostic Value of Circulatory Cancer Cells after Debulking of Advanced Ovarian Tumor

The Predictive and prognostic relevance of P53 oncogene in patients with serous epithelial ovarian cancer

Predictive and Prognostic Relevance of p53 in Patients With Serous Epithelial Ovarian Cancer

Interval debulking Surgery after Neoadjuvant Chemotherapy for Advanced Ovarian Carcinoma, Impact on Patients’ Survival

Prognostic Significance of Systematic Lymphadenectomy as Part of Primary Debulking Surgery in Patients with Ovarian Cancer

Clinico-Pathological Measures and Management of Mucinous Ovarian Cancer: Single Institutional Study

EGFR and HER2 Expression in Primary Ovarian High-Grade Serous Carcinoma and Their Prognostic Value

Improving ovarian cancer outcome by studying the clinicopathological characteristics at a tertiary care hospital